(Q54530036)

English

Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.

scientific article published on 14 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation. (English)

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Arun B

1

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Narendar D

2

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Kishan Veerabrahma

3

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

publication date

14 March 2017

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Artificial cells, nanomedicine, and biotechnology

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

46

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

1

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

126-137

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Olmesartan medoxomil

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Solid lipid nanoparticles: production, characterization and applications

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Intestinal lymphatic drug transport: an update

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Preparation of budesonide nanosuspensions for pulmonary delivery: Characterization, in vitro release and in vivo lung distribution studies

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Nanosuspensions: a promising drug delivery strategy.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Development and characterization of solid oral dosage form incorporating candesartan nanoparticles

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding.

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying

1 reference

https://api.crossref.org/works/10.1080%2F21691401.2017.1299160

21 January 2018

Identifiers

10.1080/21691401.2017.1299160

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

1 reference

Europe PubMed Central

31 May 2018

http://europepmc.org/abstract/MED/28290712

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54530036&oldid=2143698431"